CN109996551A - 从植物源中选择性提取大麻素的方法 - Google Patents
从植物源中选择性提取大麻素的方法 Download PDFInfo
- Publication number
- CN109996551A CN109996551A CN201780073017.1A CN201780073017A CN109996551A CN 109996551 A CN109996551 A CN 109996551A CN 201780073017 A CN201780073017 A CN 201780073017A CN 109996551 A CN109996551 A CN 109996551A
- Authority
- CN
- China
- Prior art keywords
- medium
- cannboid
- cbd
- situation
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL248150A IL248150B (en) | 2016-09-29 | 2016-09-29 | A method for selective extraction of cannabinoid from plant origin |
IL248150 | 2016-09-29 | ||
PCT/IL2017/051099 WO2018061009A1 (en) | 2016-09-29 | 2017-09-28 | Method for selective extraction of cannabinoids from a plant source |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109996551A true CN109996551A (zh) | 2019-07-09 |
Family
ID=57907553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780073017.1A Pending CN109996551A (zh) | 2016-09-29 | 2017-09-28 | 从植物源中选择性提取大麻素的方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US11666618B2 (ja) |
EP (1) | EP3518950A1 (ja) |
JP (1) | JP7265264B2 (ja) |
KR (1) | KR102569534B1 (ja) |
CN (1) | CN109996551A (ja) |
AU (1) | AU2017335724B2 (ja) |
BR (1) | BR112019006081B1 (ja) |
CA (1) | CA3038474A1 (ja) |
IL (1) | IL248150B (ja) |
MX (1) | MX2019003736A (ja) |
NZ (1) | NZ752820A (ja) |
WO (1) | WO2018061009A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110200953A (zh) * | 2019-06-15 | 2019-09-06 | 汉义生物科技(北京)有限公司 | 大麻素在制备吸入给药药物中的应用 |
CN114727972A (zh) * | 2019-11-19 | 2022-07-08 | 吉伟研究有限公司 | 大麻二酚型大麻素化合物 |
CN114761572A (zh) * | 2019-08-27 | 2022-07-15 | 赫博利生物科技股份公司 | 大麻素浓缩物和分离物、获得该大麻素浓缩物和分离物的方法及其用途 |
CN115551528A (zh) * | 2020-01-24 | 2022-12-30 | 嘉露酒庄 | 用于处理和稳定植物材料的系统和方法 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | A method for selective extraction of cannabinoid from plant origin |
IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
CA3055225A1 (en) | 2018-02-07 | 2019-08-15 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
WO2019207554A1 (en) * | 2018-04-27 | 2019-10-31 | Radient Technologies Inc. | Extraction of compounds from cannabis biomass using food-grade solvent |
GB201806953D0 (en) * | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
US11166933B2 (en) | 2018-05-03 | 2021-11-09 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
US10897925B2 (en) * | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
EP3833369A4 (en) | 2018-08-08 | 2022-05-04 | Neptune Wellness Solutions Inc. | PROCESS FOR COLD EXTRACTION OF CANNABINOIDS AND TERPENES FROM CANNABIS BY ORGANIC SOLVENTS |
CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
WO2020086291A1 (en) * | 2018-10-22 | 2020-04-30 | Jones Lisa Marie | Topical compositions incorporating cannabis |
WO2020109418A1 (fr) * | 2018-11-27 | 2020-06-04 | Avignon Universite | Procédé d'extraction de substances d'intérêt |
CA3122481A1 (en) * | 2018-12-11 | 2020-06-18 | Naturalia Ingredients S.R.L. | Extraction method and composition obtained therefrom |
WO2020176806A1 (en) * | 2019-02-27 | 2020-09-03 | 3-Delta, Inc. | Compositions that contain lipophilic plant material and surfactant, and related methods |
US10993928B2 (en) * | 2019-04-26 | 2021-05-04 | Natural Extraction Systems, LLC | Compositions comprising non-crystalline forms of cannabidiol |
US20220296482A1 (en) | 2019-06-11 | 2022-09-22 | Symrise Ag | Synthesis and purification of cannabigerol and its application |
MX2022001634A (es) * | 2019-08-08 | 2022-05-11 | Neptune Wellness Solutions Inc | Formulaciones orales de extractos de cannabis y metodos para elaborar las mismas. |
WO2021076159A1 (en) * | 2019-10-14 | 2021-04-22 | Capna Ip Capital, Llc | Improved methods to reduce chlorophyll co-extraction through extraction of select moieties essential oils and aromatic isolates |
US10941131B1 (en) * | 2019-10-28 | 2021-03-09 | Pure Tonic Concentrates, LLC | Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures |
CA3163788A1 (en) | 2019-12-06 | 2021-06-10 | JLABS Beauty LLC | Topical compositions containing rose oil and cannabidiol and methods of making and using the same |
US11291699B1 (en) | 2019-12-13 | 2022-04-05 | Delmarva Hemp, LLC | Method for solvent-free extraction and concentration of full spectrum of cannabinoids in a carrier oil |
US10919828B1 (en) * | 2020-02-14 | 2021-02-16 | Aicardo Roa-Espinosa | Process for manufacturing cannabidiol |
GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
US11660581B2 (en) | 2020-04-30 | 2023-05-30 | Hydro Dynamics, Inc. | System and method for treatment of plants for synthesis of compounds therefrom |
AU2021276680A1 (en) | 2020-05-22 | 2023-01-19 | Ilera Derm LLC | Compositions for treating acne and dermatological conditions |
US20220064566A1 (en) * | 2020-09-02 | 2022-03-03 | Michael V. Zumpano | Compositions that contain lipophilic plant material and surfactant, and related methods |
AU2020481908A1 (en) * | 2020-12-16 | 2023-06-29 | TARK, Hye Ryun | Method for preparing vegetable oil emulsion using cannabidiol oil |
IL309776A (en) * | 2021-07-01 | 2024-02-01 | Ananda Scient Inc | Methods of treating pain using cannabinoids |
KR102461951B1 (ko) | 2021-09-23 | 2022-11-03 | 재단법인춘천바이오산업진흥원 | 반응표면분석법을 활용한 대마 초임계 추출 최적화 |
US11911427B2 (en) | 2022-03-12 | 2024-02-27 | Wilhelm Rumpf | Extraction and infusion of active components from plant materials |
WO2023209046A1 (en) | 2022-04-27 | 2023-11-02 | GW Research Limited | Treatment of spasticity and pain in renally-impaired patients |
WO2024044849A1 (en) * | 2022-08-30 | 2024-03-07 | Micellae Delivery Systems Inc. | Dilutable compositions and processes for extracting and refining poorly water-soluble polar oils from biomass |
WO2024115774A1 (en) | 2022-12-02 | 2024-06-06 | GW Research Limited | Cannabinoids for treating essential tremor in patients |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1547479A (zh) * | 2001-03-06 | 2004-11-17 | ��֢�о���˹��˹��Э�� | 由大麻提取物制成的药物组合物 |
US20070104741A1 (en) * | 2005-11-07 | 2007-05-10 | Murty Pharmaceuticals, Inc. | Delivery of tetrahydrocannabinol |
CN104619318A (zh) * | 2012-05-03 | 2015-05-13 | 回音制药公司 | 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法 |
CN105535111A (zh) * | 2016-02-16 | 2016-05-04 | 晋城市汉恩宝生物科技有限公司 | 一种富含大麻二酚的火麻浸膏及其制备方法 |
CN105997985A (zh) * | 2016-06-14 | 2016-10-12 | 云南瑞酚生物科技有限公司 | 一种大麻提取物在制备治疗痛风药物中的应用 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155698A4 (en) | 1999-01-29 | 2003-01-15 | Nitto Kasei Co Ltd | ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY |
IL165528A (en) | 2002-06-12 | 2010-11-30 | Yissum Res Dev Co | Liquid concentrates of self-assembled nano-sized structures and their use as carriers for active components |
US7182950B2 (en) | 2002-06-12 | 2007-02-27 | Nutralease Ltd. | Nano-sized self-assembled liquid dilutable vehicles |
JP2006511613A (ja) | 2002-12-18 | 2006-04-06 | アナコア ファーマシューティカルズ インコーポレイテッド | ボロン酸複合体を含む抗生物質および使用法 |
EP1684776A1 (en) | 2003-07-25 | 2006-08-02 | Washington State University Research Foundation | Natural astaxanthin extract reduces dna oxidation |
GB0504950D0 (en) | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
WO2008058366A1 (en) | 2006-09-28 | 2008-05-22 | Université de Montréal | Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof |
AU2008259821B2 (en) | 2007-06-04 | 2013-09-05 | Pressure Biosciences Inc. | Pressure-enhanced extraction and partitioning of molecules |
IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
JP5149837B2 (ja) | 2009-02-27 | 2013-02-20 | Jx日鉱日石エネルギー株式会社 | カロテノイドの製造方法 |
CN102145084A (zh) | 2011-04-19 | 2011-08-10 | 宁夏医科大学 | 枸杞籽油自微乳化纳米组合物及其生产方法 |
WO2013009928A1 (en) | 2011-07-11 | 2013-01-17 | Organic Medical Research | Cannabinoid formulations |
CN103027863B (zh) | 2011-09-30 | 2015-02-25 | 伽蓝(集团)股份有限公司 | 一种含有牡丹提取物的微乳液及其制备方法和应用 |
ES2739194T3 (es) | 2012-01-19 | 2020-01-29 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Formulación y método para aumentar la biodisponibilidad oral de fármacos |
US20140056828A1 (en) | 2012-08-21 | 2014-02-27 | Indiran Pather | Novel formulations and uses for curcuma extracts |
CH706963B1 (de) * | 2012-08-30 | 2016-03-31 | Ai Fame Gmbh | Verfahren zur Herstellung eines Cannabis enthaltenden Präparates. |
CN103110582A (zh) | 2013-03-04 | 2013-05-22 | 上海医药工业研究院 | 大麻酚类化合物微乳剂及其制备方法 |
WO2015011724A2 (en) | 2013-07-22 | 2015-01-29 | Kms Health Center Pvt Ltd | A novel omega -3 fatty acid composition with a plant extract |
CN103690580B (zh) | 2013-11-07 | 2016-01-20 | 山西中医学院 | 穿心莲的微乳提取方法及其提取物 |
US9340475B2 (en) | 2014-07-02 | 2016-05-17 | Cv Sciences, Inc. | Process for generating hemp oil with a high cannabidiol (CBD) content |
WO2016022936A1 (en) | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
TWI679029B (zh) | 2014-08-29 | 2019-12-11 | 日商富士化學工業股份有限公司 | 乳化組合物 |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
CA2965493C (en) * | 2014-10-21 | 2021-12-07 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
AU2016231788A1 (en) * | 2015-03-19 | 2017-10-12 | One World Cannabis Ltd | Preparations of cannabis emulsions and methods thereof |
US10342747B2 (en) | 2015-12-16 | 2019-07-09 | PPP&C Inc. | Apparatus and method for preparing cosmeceutical ingredients containing epi-dermal delivery mechanisms |
US10328216B2 (en) | 2016-01-20 | 2019-06-25 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation |
IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | A method for selective extraction of cannabinoid from plant origin |
-
2016
- 2016-09-29 IL IL248150A patent/IL248150B/en active IP Right Grant
-
2017
- 2017-09-28 WO PCT/IL2017/051099 patent/WO2018061009A1/en unknown
- 2017-09-28 US US16/338,259 patent/US11666618B2/en active Active
- 2017-09-28 MX MX2019003736A patent/MX2019003736A/es unknown
- 2017-09-28 EP EP17794792.6A patent/EP3518950A1/en active Pending
- 2017-09-28 CN CN201780073017.1A patent/CN109996551A/zh active Pending
- 2017-09-28 CA CA3038474A patent/CA3038474A1/en active Pending
- 2017-09-28 AU AU2017335724A patent/AU2017335724B2/en active Active
- 2017-09-28 NZ NZ752820A patent/NZ752820A/en unknown
- 2017-09-28 BR BR112019006081-2A patent/BR112019006081B1/pt active IP Right Grant
- 2017-09-28 JP JP2019516149A patent/JP7265264B2/ja active Active
- 2017-09-28 KR KR1020197012346A patent/KR102569534B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1547479A (zh) * | 2001-03-06 | 2004-11-17 | ��֢�о���˹��˹��Э�� | 由大麻提取物制成的药物组合物 |
US20070104741A1 (en) * | 2005-11-07 | 2007-05-10 | Murty Pharmaceuticals, Inc. | Delivery of tetrahydrocannabinol |
CN104619318A (zh) * | 2012-05-03 | 2015-05-13 | 回音制药公司 | 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法 |
CN105535111A (zh) * | 2016-02-16 | 2016-05-04 | 晋城市汉恩宝生物科技有限公司 | 一种富含大麻二酚的火麻浸膏及其制备方法 |
CN105997985A (zh) * | 2016-06-14 | 2016-10-12 | 云南瑞酚生物科技有限公司 | 一种大麻提取物在制备治疗痛风药物中的应用 |
Non-Patent Citations (1)
Title |
---|
杨华等: "O/W型微乳用于提取中药丹参的实验研究", 《中国中药杂志》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110200953A (zh) * | 2019-06-15 | 2019-09-06 | 汉义生物科技(北京)有限公司 | 大麻素在制备吸入给药药物中的应用 |
CN114761572A (zh) * | 2019-08-27 | 2022-07-15 | 赫博利生物科技股份公司 | 大麻素浓缩物和分离物、获得该大麻素浓缩物和分离物的方法及其用途 |
CN114761572B (zh) * | 2019-08-27 | 2024-07-12 | 赫博利生物科技股份公司 | 大麻素浓缩物和分离物、获得该大麻素浓缩物和分离物的方法及其用途 |
CN114727972A (zh) * | 2019-11-19 | 2022-07-08 | 吉伟研究有限公司 | 大麻二酚型大麻素化合物 |
CN115551528A (zh) * | 2020-01-24 | 2022-12-30 | 嘉露酒庄 | 用于处理和稳定植物材料的系统和方法 |
US11946091B2 (en) | 2020-01-24 | 2024-04-02 | E. & J. Gallo Winery | Methods for processing plant materials and producing dried products |
Also Published As
Publication number | Publication date |
---|---|
US11666618B2 (en) | 2023-06-06 |
IL248150A0 (en) | 2017-01-31 |
WO2018061009A1 (en) | 2018-04-05 |
JP2020502040A (ja) | 2020-01-23 |
JP7265264B2 (ja) | 2023-04-26 |
IL248150B (en) | 2018-05-31 |
MX2019003736A (es) | 2019-10-09 |
US20190231833A1 (en) | 2019-08-01 |
AU2017335724B2 (en) | 2023-05-25 |
KR102569534B1 (ko) | 2023-08-22 |
AU2017335724A1 (en) | 2019-05-16 |
BR112019006081A2 (pt) | 2019-06-18 |
EP3518950A1 (en) | 2019-08-07 |
KR20190084036A (ko) | 2019-07-15 |
BR112019006081B1 (pt) | 2023-02-07 |
NZ752820A (en) | 2022-09-30 |
CA3038474A1 (en) | 2018-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109996551A (zh) | 从植物源中选择性提取大麻素的方法 | |
US11819491B2 (en) | Dilutable formulations of cannabinoids and processes for their preparation | |
US10709747B2 (en) | Encapsulated cannabinoid formulations for oral delivery | |
US20220088099A1 (en) | Method for extraction of an agent from a plant source | |
CN116459170A (zh) | 一种脂质体组合物及其在化妆品中的应用 | |
TWI547280B (zh) | 穩定醫藥組合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |